Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yves Beguin

Showing results (121-130 of 243) with videos related to

Pageof 25
Sort By:
Bulletin Du Cancer|April 17, 2024
[Hematological toxicities post-CAR-T cells: Recommendations of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]Tamim Alsuliman, Clotilde Aubrun, Jacques Olivier Bay, et al.
Plos One|November 22, 2014
Establishment of a murine graft-versus-myeloma model using allogeneic stem cell transplantationMarilène Binsfeld, Yves Beguin, Ludovic Belle, et al.
Bone Marrow Transplantation|June 26, 2021
Itacitinib prevents xenogeneic GVHD in humanized miceJustine Courtois, Caroline Ritacco, Sophie Dubois, et al.
Bulletin Du Cancer|July 3, 2021
[How to deal with an unexpected event that could alter the normal activity of cellular therapy? Recommendations of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]Jacques Olivier Bay, Yves Beguin, Alexandre Carpentier, et al.
Current Research in Translational Medicine|August 30, 2024
Feasibility of co-transplantation of umbilical cord blood and third-party mesenchymal stromal cells after (non)myeloablative conditioning in patients with hematological malignanciesSimon Planken, Ann De Becker, Tessa Kerre, et al.
Therapeutic Advances in Hematology|October 2, 2023
Alterations of erythropoiesis in Covid-19 patients: prevalence of positive Coombs tests and iron metabolismLéa Schmitz, Michelle Pirotte, Alizée Lebeau, et al.
Neuroimmunomodulation|January 21, 2012
Expression of the growth hormone/insulin-like growth factor axis during Balb/c thymus ontogeny and effects of growth hormone upon ex vivo T cell differentiationHamid Kermani, Lindsay Goffinet, Marie Mottet, et al.
Bulletin Du Cancer|September 14, 2020
[Allogeneic hematopoietic stem cell transplant in children and adults with sickle cell disease: Indications and modalities]Nathalie Dhédin, Catherine Paillard, Jean-Hugues Dalle, et al.
Journal of Hepatology|March 13, 2017
Infusion of mesenchymal stromal cells after deceased liver transplantation: A phase I-II, open-label, clinical studyOlivier Detry, Morgan Vandermeulen, Marie-Hélène Delbouille, et al.
Current Hematologic Malignancy Reports|January 7, 2014
Thinking out of the box--new approaches to controlling GVHDFrédéric Baron, Stéphanie Humblet-Baron, Grégory Ehx, et al.
Pageof 25

Showing results (121-130 of 243) with videos related to

Sort By:
Pageof 25
Bulletin Du Cancer|April 17, 2024
[Hematological toxicities post-CAR-T cells: Recommendations of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]Tamim Alsuliman, Clotilde Aubrun, Jacques Olivier Bay, et al.
Plos One|November 22, 2014
Establishment of a murine graft-versus-myeloma model using allogeneic stem cell transplantationMarilène Binsfeld, Yves Beguin, Ludovic Belle, et al.
Bone Marrow Transplantation|June 26, 2021
Itacitinib prevents xenogeneic GVHD in humanized miceJustine Courtois, Caroline Ritacco, Sophie Dubois, et al.
Bulletin Du Cancer|July 3, 2021
[How to deal with an unexpected event that could alter the normal activity of cellular therapy? Recommendations of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]Jacques Olivier Bay, Yves Beguin, Alexandre Carpentier, et al.
Current Research in Translational Medicine|August 30, 2024
Feasibility of co-transplantation of umbilical cord blood and third-party mesenchymal stromal cells after (non)myeloablative conditioning in patients with hematological malignanciesSimon Planken, Ann De Becker, Tessa Kerre, et al.
Therapeutic Advances in Hematology|October 2, 2023
Alterations of erythropoiesis in Covid-19 patients: prevalence of positive Coombs tests and iron metabolismLéa Schmitz, Michelle Pirotte, Alizée Lebeau, et al.
Neuroimmunomodulation|January 21, 2012
Expression of the growth hormone/insulin-like growth factor axis during Balb/c thymus ontogeny and effects of growth hormone upon ex vivo T cell differentiationHamid Kermani, Lindsay Goffinet, Marie Mottet, et al.
Bulletin Du Cancer|September 14, 2020
[Allogeneic hematopoietic stem cell transplant in children and adults with sickle cell disease: Indications and modalities]Nathalie Dhédin, Catherine Paillard, Jean-Hugues Dalle, et al.
Journal of Hepatology|March 13, 2017
Infusion of mesenchymal stromal cells after deceased liver transplantation: A phase I-II, open-label, clinical studyOlivier Detry, Morgan Vandermeulen, Marie-Hélène Delbouille, et al.
Current Hematologic Malignancy Reports|January 7, 2014
Thinking out of the box--new approaches to controlling GVHDFrédéric Baron, Stéphanie Humblet-Baron, Grégory Ehx, et al.
Pageof 25